Metabolic Syndrome May Exacerbate Macular and Retinal Damage in Psoriasis Vulgaris

Basit Öğe Kaydı
dc.authoridHatipoglu, Esra/0000-0001-8361-8866
dc.authoridGüçlü, Hande/0000-0002-3021-0493
dc.authoridHatipoglu, Esra/0000-0001-8361-8866
dc.authorwosidHatipoglu, Esra/I-1793-2013
dc.authorwosidKorkmaz, Selma/JRX-3713-2023
dc.authorwosidKorkmaz, Selma/W-4142-2017
dc.authorwosidOzal, Sadık Altan/B-5123-2019
dc.authorwosidGüçlü, Hande/AAW-9756-2020
dc.authorwosidHatipoglu, Esra/ABI-7268-2020
dc.contributor.authorKorkmaz, Selma
dc.contributor.authorGuclu, Hande
dc.contributor.authorHatipoglu, Esra Sueheda
dc.contributor.authorFicicioglu, Sezin
dc.contributor.authorGurlu, Vuslat
dc.contributor.authorOzal, Sadik Altan
dc.date.accessioned2024-06-12T11:07:58Z
dc.date.available2024-06-12T11:07:58Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: To evaluate whether cases with both psoriasis and metabolic syndrome are prone to retinal and macular changes. Materials and Methods: A total of 174 eyes of 87 subjects were evaluated. Of the 87 subjects, 24 had psoriasis, 19 had psoriasis and metabolic syndrome, 18 had metabolic syndrome only and 26 were healthy subjects. Biochemical analysis, anthropometric, blood pressure and optical coherence tomography measurements and thickness analysis were obtained for each case. Results: The superior retinal nerve fibre layer thickness was significantly lower in the psoriasis and metabolic syndrome group than in the psoriasis group. For all parafoveal quadrants, the ganglion cell complex thickness was statistically significantly lower in the psoriasis group than in the healthy group. The central macula was thinnest in the healthy group among the four groups. Conclusions: Psoriasis can cause retinal changes, and metabolic syndrome may cause additional damage in the retina and macula in cases with psoriasis.en_US
dc.identifier.doi10.1080/09273948.2018.1476556
dc.identifier.endpage804en_US
dc.identifier.issn0927-3948
dc.identifier.issn1744-5078
dc.identifier.issue5en_US
dc.identifier.pmid29847216en_US
dc.identifier.scopus2-s2.0-85047946952en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage798en_US
dc.identifier.urihttps://doi.org/10.1080/09273948.2018.1476556
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22259
dc.identifier.volume27en_US
dc.identifier.wosWOS:000480636000016en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofOcular Immunology And Inflammationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMaculaen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectOptical Coherence Tomographyen_US
dc.subjectPsoriasisen_US
dc.subjectRetinaen_US
dc.subjectEndothelial Dysfunctionen_US
dc.subjectOptic-Nerveen_US
dc.subjectTnf-Alphaen_US
dc.subjectLayeren_US
dc.subjectInflammationen_US
dc.subjectThicknessen_US
dc.subjectArthritisen_US
dc.subjectIndexen_US
dc.subjectRisken_US
dc.titleMetabolic Syndrome May Exacerbate Macular and Retinal Damage in Psoriasis Vulgarisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu